Literature DB >> 7812548

Proinflammatory cytokines in hypersensitivity pneumonitis.

M Denis1.   

Abstract

We examined the synthesis and release of the proinflammatory cytokines macrophage inflammatory protein-1 alpha (MIP-1 alpha) and interleukin-8 (IL-8) in the context of subjects with hypersensitivity pneumonitis (HP). Subjects with acute HP were found to have alveolar macrophages that released high levels of MIP-1 alpha and IL-8, whereas control subjects had cells that released low levels of these factors. Bronchoalveolar lavage fluid from HP subjects contained low but significant levels of MIP-1 alpha and IL-8. Immunohistochemistry revealed that macrophages from acute HP subjects expressed MIP-1 alpha and IL-8 at high levels. Treatment of acute HP subjects by contact avoidance or by corticosteroids reduced the synthesis of both cytokines. Supernatants of alveolar macrophages from subjects with HP were shown to attract activated CD8+ T lymphocytes, and this activity was significantly inhibited by anti-MIP-1 alpha. MIP-1 alpha and IL-8 may be important inflammatory cytokines in the development of HP via their capacity to attract inflammatory cells (activated CD8+ T lymphocytes and neutrophils, respectively) into the airways of subjects with HP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7812548     DOI: 10.1164/ajrccm.151.1.7812548

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

1.  Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).

Authors:  M Seki; J I Kadota; Y Higashiyama; K Iida; T Iwashita; E Sasaki; S Maesaki; K Tomono; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  The role of MIP-1alpha in experimental hypersensitivity pneumonitis.

Authors:  M Schuyler; K Gott; V French
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis.

Authors:  Elisabetta Volpe; Giulia Cappelli; Manuela Grassi; Angelo Martino; Annalucia Serafino; Vittorio Colizzi; Nunzia Sanarico; Francesca Mariani
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

4.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent.

Authors:  Urvashi Bhan; Michael J Newstead; Xianying Zeng; Megan N Ballinger; Louis R Standiford; Theodore J Standiford
Journal:  Am J Pathol       Date:  2011-10-05       Impact factor: 4.307

6.  Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis.

Authors:  K Iida; J Kadota; K Kawakami; Y Matsubara; R Shirai; S Kohno
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

Review 7.  Takes your breath away--the immunology of allergic alveolitis.

Authors:  C McSharry; K Anderson; S J Bourke; G Boyd
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

8.  Interstitial Lung Disease in Children Older Than 2 Years.

Authors:  Timothy J Vece; Leland L Fan
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

9.  Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Judy M Opalek; Sara McMaken; Christie A Newland; James M O'Brien; Melissa G Hunter; Benjamin D Bringardner; Martha M Monick; David R Brigstock; Paul C Stromberg; Gary W Hunninghake; Clay B Marsh
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

10.  Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis.

Authors:  Hyo Jin Park; Hye Sung Kim; Doo Hyun Chung
Journal:  Immune Netw       Date:  2010-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.